Novartis Japan Unit Shoots For Leading Role By End Of 2016
This article was originally published in PharmAsia News
Executive Summary
Novartis Pharma KK aims to be seen as one of Japan’s leading drug makers within the next four years, according to President Hiroyuki Mitani.